Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: Contributions from the Dutch Lynch syndrome registry

Hans F A Vasen, Mary E Velthuizen, Jan H Kleibeuker, Fred H Menko, Fokke M Nagengast, Annemieke Cats, Andrea E van der Meulen-de Jong, Martijn H Breuning, J.A. Roukema, Inge van Leeuwen-Cornelisse, Wouter H de Vos Tot Nederveen Cappel, Juul T Wijnen

Research output: Contribution to journalArticleScientificpeer-review

8 Citations (Scopus)

Abstract

The Dutch Hereditary Cancer Registry was established in 1985 with the support of the Ministry of Health (VWS). The aims of the registry are: (1) to promote the identification of families with hereditary cancer, (2) to encourage the participation in surveillance programs of individuals at high risk, (3) to ensure the continuity of lifelong surveillance examinations, and (4) to promote research, in particular the improvement of surveillance protocols. During its early days the registry provided assistance with family investigations and the collection of medical data, and recommended surveillance when a family fulfilled specific diagnostic criteria. Since 2000 the registry has focused on family follow-up, and ensuring the quality of surveillance programs and appropriate clinical management. Since its founding, the registry has identified over 10,000 high-risk individuals with a diverse array of hereditary cancer syndromes. All were encouraged to participate in prevention programmes. The registry has published a number of studies that evaluated the outcome of surveillance protocols for colorectal cancer (CRC) in Lynch syndrome, as well as in familial colorectal cancer. In 2006, evaluation of the effect of registration and colonoscopic surveillance on the mortality rate associated with colorectal cancer (CRC) showed that the policy led to a substantial decrease in the mortality rate associated with CRC. Following discovery of MMR gene defects, the first predictive model that could select families for genetic testing was published by the Leiden group. In addition, over the years the registry has produced many cancer risk studies that have helped to develop appropriate surveillance protocols. Hereditary cancer registries in general, and the Lynch syndrome registry in particular, play an important role in improving the clinical management of affected families.

Original languageEnglish
Pages (from-to)429-435
JournalFamilial Cancer
Volume15
Issue number3
DOIs
Publication statusPublished - 2016

Fingerprint Dive into the research topics of 'Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: Contributions from the Dutch Lynch syndrome registry'. Together they form a unique fingerprint.

Cite this